Dirk Schriefer

783 total citations
33 papers, 460 citations indexed

About

Dirk Schriefer is a scholar working on Pathology and Forensic Medicine, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Dirk Schriefer has authored 33 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 6 papers in Economics and Econometrics and 5 papers in Epidemiology. Recurrent topics in Dirk Schriefer's work include Multiple Sclerosis Research Studies (24 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Health and Medical Studies (3 papers). Dirk Schriefer is often cited by papers focused on Multiple Sclerosis Research Studies (24 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Health and Medical Studies (3 papers). Dirk Schriefer collaborates with scholars based in Germany and Switzerland. Dirk Schriefer's co-authors include Tjalf Ziemssen, Hernán Inojosa, Rocco Haase, Maria Scholz, Isabel Voigt, Katja Akgün, Benjamin Ettle, Stefanie J. Klug, Anja Dillenseger and Christian Cornelissen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Dirk Schriefer

27 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Schriefer Germany 13 292 74 60 46 46 33 460
Raimar Kern Germany 12 332 1.1× 64 0.9× 63 1.1× 44 1.0× 53 1.2× 22 432
Mitzi Williams United States 13 328 1.1× 55 0.7× 62 1.0× 75 1.6× 21 0.5× 37 461
R. Macdonell Australia 3 252 0.9× 77 1.0× 55 0.9× 83 1.8× 42 0.9× 5 389
Sophie Kulaga Canada 8 441 1.5× 85 1.1× 119 2.0× 59 1.3× 88 1.9× 10 704
Amy Perrin Ross United States 12 265 0.9× 76 1.0× 47 0.8× 59 1.3× 30 0.7× 35 425
Marguerite Duggan Ireland 11 285 1.0× 64 0.9× 28 0.5× 39 0.8× 52 1.1× 14 350
Ahmed Z. Obeidat United States 12 119 0.4× 133 1.8× 57 0.9× 37 0.8× 43 0.9× 45 383
Elizabeth Crabtree United States 7 235 0.8× 97 1.3× 51 0.8× 34 0.7× 14 0.3× 9 389
Howard Zwibel United States 9 430 1.5× 142 1.9× 47 0.8× 63 1.4× 69 1.5× 12 512
Salim Chahin United States 14 339 1.2× 158 2.1× 30 0.5× 65 1.4× 25 0.5× 28 460

Countries citing papers authored by Dirk Schriefer

Since Specialization
Citations

This map shows the geographic impact of Dirk Schriefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Schriefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Schriefer more than expected).

Fields of papers citing papers by Dirk Schriefer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Schriefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Schriefer. The network helps show where Dirk Schriefer may publish in the future.

Co-authorship network of co-authors of Dirk Schriefer

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Schriefer. A scholar is included among the top collaborators of Dirk Schriefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Schriefer. Dirk Schriefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inojosa, Hernán, et al.. (2025). Cost–consequence analysis of early vs. delayed natalizumab use in highly active relapsing–remitting multiple sclerosis: a simulation study. Journal of Neurology. 272(2). 153–153. 1 indexed citations
2.
Schriefer, Dirk, et al.. (2025). Experiences of People with Multiple Sclerosis in Sensor-Based Jump Assessment. Bioengineering. 12(6). 610–610.
3.
4.
Inojosa, Hernán, Dirk Schriefer, Anja Dillenseger, et al.. (2024). Insights from Real-World Practice: The Dynamics of SARS-CoV-2 Infections and Vaccinations in a Large German Multiple Sclerosis Cohort. Vaccines. 12(3). 265–265. 2 indexed citations
5.
Hartmann, Maximilian, et al.. (2024). The Association of Age, Sex, and BMI on Lower Limb Neuromuscular and Muscle Mechanical Function in People with Multiple Sclerosis. Biomedicines. 12(5). 971–971. 2 indexed citations
6.
Hartmann, Maximilian, et al.. (2024). Sensitive Identification of Asymmetries and Neuromuscular Deficits in Lower Limb Function in Early Multiple Sclerosis. Neurorehabilitation and neural repair. 38(8). 570–581. 2 indexed citations
7.
8.
Schriefer, Dirk, et al.. (2023). Countermovement Jumps Detect Subtle Motor Deficits in People with Multiple Sclerosis below the Clinical Threshold. Biomedicines. 11(3). 774–774. 5 indexed citations
9.
Schoffer, Olaf, Dirk Schriefer, Andreas Werblow, et al.. (2023). Modelling the effect of demographic change and healthcare infrastructure on the patient structure in German hospitals – a longitudinal national study based on official hospital statistics. BMC Health Services Research. 23(1). 1081–1081. 3 indexed citations
10.
Dillenseger, Anja, Hernán Inojosa, Rocco Haase, et al.. (2021). Digital Biomarkers in Multiple Sclerosis. Brain Sciences. 11(11). 1519–1519. 68 indexed citations
11.
12.
Haase, Rocco, Raimar Kern, Dirk Schriefer, et al.. (2020). The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study. Journal of Medical Internet Research. 22(3). e17921–e17921. 18 indexed citations
13.
Inojosa, Hernán, et al.. (2020). Visual Feedback and Postural Control in Multiple Sclerosis. Journal of Clinical Medicine. 9(5). 1291–1291. 9 indexed citations
14.
Schriefer, Dirk, et al.. (2020). Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Schriefer, Dirk, et al.. (2020). Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis. PharmacoEconomics. 38(8). 883–892. 12 indexed citations
16.
Schriefer, Dirk, Rocco Haase, Jennifer S. Kullmann, & Tjalf Ziemssen. (2020). <p>Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study</p>. Patient Preference and Adherence. Volume 14. 869–880. 18 indexed citations
17.
Inojosa, Hernán, Maria Scholz, Rocco Haase, et al.. (2020). The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice. Frontiers in Neuroscience. 14. 582046–582046. 14 indexed citations
18.
Inojosa, Hernán, et al.. (2020). Balance Testing in Multiple Sclerosis—Improving Neurological Assessment With Static Posturography?. Frontiers in Neurology. 11. 135–135. 17 indexed citations
19.
Inojosa, Hernán, Dirk Schriefer, & Tjalf Ziemssen. (2020). Clinical outcome measures in multiple sclerosis: A review. Autoimmunity Reviews. 19(5). 102512–102512. 107 indexed citations
20.
Schriefer, Dirk, et al.. (2019). Differentiating societal costs of disability worsening in multiple sclerosis. Journal of Neurology. 267(4). 1035–1042. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raimar Kern Breakdown of academic impact, for papers by Mitzi Williams Breakdown of academic impact, for papers by R. Macdonell Breakdown of academic impact, for papers by Sophie Kulaga Breakdown of academic impact, for papers by Amy Perrin Ross Breakdown of academic impact, for papers by Marguerite Duggan Breakdown of academic impact, for papers by Ahmed Z. Obeidat Breakdown of academic impact, for papers by Elizabeth Crabtree Breakdown of academic impact, for papers by Howard Zwibel Breakdown of academic impact, for papers by Salim Chahin
Rankless by CCL
2026